Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo

Br J Cancer. 1986 Nov;54(5):743-8. doi: 10.1038/bjc.1986.235.

Abstract

The activity of theophylline and disodium cromoglycate was tested on adriamycin-induced histamine release in vitro and on adriamycin cardiotoxicity in vivo. Both substances significantly inhibited the release of histamine induced by 100 micrograms ml-1 of adriamycin on rat peritoneal cells and produced significant protection against adriamycin-mediated acute and chronic cardiotoxicity in mice. N-acetylcysteine, a free radical scavenger, successfully used in the prevention of the cardiomyopathy, was also found to be an inhibitor of histamine release induced by adriamycin and compound 48/80 on rat peritoneal cells. This study further supports the hypothesis that the release of histamine may be involved in the pathogenesis of anthracycline cardiotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Animals
  • Cardiomyopathies / chemically induced*
  • Cardiomyopathies / prevention & control
  • Cromolyn Sodium / pharmacology
  • Dose-Response Relationship, Drug
  • Doxorubicin / adverse effects
  • Doxorubicin / antagonists & inhibitors*
  • Histamine Release / drug effects*
  • Male
  • Mast Cells / drug effects
  • Rats
  • Rats, Inbred Strains
  • Theophylline / pharmacology
  • p-Methoxy-N-methylphenethylamine / antagonists & inhibitors

Substances

  • p-Methoxy-N-methylphenethylamine
  • Doxorubicin
  • Theophylline
  • Cromolyn Sodium
  • Acetylcysteine